blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2369341

EP2369341 - Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.05.2015
Database last updated on 24.07.2024
Most recent event   Tooltip15.05.2015Application deemed to be withdrawnpublished on 17.06.2015  [2015/25]
Applicant(s)For all designated states
Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego, CA 92121 / US
[2013/25]
Former [2011/39]For all designated states
Arena Pharmaceuticals, Inc.
6166 Nancy Ridge Drive
San Diego, CA 92121 / US
Inventor(s)01 / Chu, Zhi-Liang
11489 Creekstone Lane
San Diego CA 92128 / US
02 / Leonard, James N.
10667 Viacha Drive
San Diego CA 92124 / US
 [2011/39]
Representative(s)Tollervey, Rebecca Marie, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2011/39]Tollervey, Rebecca Marie, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date10009158.610.04.2007
[2011/39]
Priority number, dateUS20060791550P11.04.2006         Original published format: US 791550 P
[2011/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2369341
Date:28.09.2011
Language:EN
[2011/39]
Type: A3 Search report 
No.:EP2369341
Date:04.01.2012
Language:EN
[2012/01]
Search report(s)(Supplementary) European search report - dispatched on:EP06.12.2011
ClassificationIPC:G01N33/50
[2011/39]
CPC:
G01N33/74 (EP,US); G01N33/50 (KR); A61P1/08 (EP);
A61P19/00 (EP); A61P19/10 (EP); A61P3/10 (EP);
A61P31/08 (EP); A61P31/10 (EP); A61P43/00 (EP);
A61P5/50 (EP); G01N33/48 (KR); G01N33/5005 (EP,US);
G01N33/53 (KR); G01N2333/726 (EP,US); G01N2800/108 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/39]
Extension statesAL21.09.2010
BA21.09.2010
HR21.09.2010
MK21.09.2010
RS21.09.2010
TitleGerman:Verfahren zur Verwendung des GPR119-Rezeptors zur Identifizierung von Verbindungen zur Erhöhung der Knochenmasse eines Individuums[2011/39]
English:Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual[2011/39]
French:Procédés d'utilisation de récepteur gpr119 pour identifier les composants utiles pour augmenter la masse osseuse chez un individu[2011/39]
Examination procedure21.09.2010Examination requested  [2011/39]
18.10.2012Amendment by applicant (claims and/or description)
27.06.2014Despatch of a communication from the examining division (Time limit: M06)
08.01.2015Application deemed to be withdrawn, date of legal effect  [2015/25]
04.02.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/25]
Parent application(s)   TooltipEP07755238.8  / EP1971862
Divisional application(s)EP11165164.2  / EP2402750
EP11165314.3  / EP2410330
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
18.10.2012Request for further processing filed
18.10.2012Full payment received (date of receipt of payment)
Request granted
30.10.2012Decision despatched
Fees paidRenewal fee
21.09.2010Renewal fee patent year 03
21.09.2010Renewal fee patent year 04
20.04.2011Renewal fee patent year 05
15.10.2012Renewal fee patent year 06
22.04.2013Renewal fee patent year 07
25.03.2014Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.04.201206   M06   Fee paid on   15.10.2012
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0187929  (BAYER AG [DE], et al) [X] 1-42 * pages 53,72-74 *;
 [X]WO2004065380  (ARENA PHARM INC [US], et al) [X] 1-42 * page 127 - page 212 *;
 [X]WO2005007647  (ARENA PHARM INC [US], et al) [X] 1-42 * Page 10, 127-129,146-157; page 65 - page 118 *;
 [X]WO2005007658  (ARENA PHARM INC [US], et al) [X] 1-42* page 59 - page 146 *;
 [X]  - OVERTON HILARY A ET AL, "Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents", CELL METABOLISM, (200603), vol. 3, no. 3, ISSN 1550-4131, pages 167 - 175 URL, XP002449851 [X] 1-42 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.cmet.2006.02.004
 [X]  - MAYET S ET AL, "GPR119 activation increases glucose-dependent insulin secretion in insulin-producing cells and isolated rat islets", DIABETOLOGIA, & 41ST ANNUAL MEETING OF THE EUROPEAN-ASSOCIATION-FOR-THE-STUDY-OF-DIAB ETES; ATHENS, GREECE; SEPTEMBER 10 -15, 2005, (2005), vol. 48, no. Suppl. 1, ISSN 0012-186X, page A166, XP002449852 [X] 1-42 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.